Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) previous close was $188.36 while the outstanding shares total 259.37M. The firm has a beta of 0.67, a 12-month trailing P/E
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Relative Strength Index (RSI) is 31.66, with weekly volatility at 2.45% and ATR at 5.17. The VRTX stock’s 52-week price range
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares fell to a low of $209.39 before closing at $209.93. Intraday shares traded counted 1.6 million, which was 2.67% higher
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Relative Strength Index (RSI) is 40.31, with weekly volatility at 1.84% and ATR at 4.05. The VRTX stock’s 52-week price range
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
© 2024, Fueled by Smart TechOne
